Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 1
2005 1
2006 1
2007 1
2008 6
2010 2
2011 1
2012 4
2013 2
2015 3
2017 1
2018 1
2019 1
2020 1
2021 2
2022 4
2023 5
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020).
Paccoud O, Desnos-Ollivier M, Persat F, Demar M, Boukris-Sitbon K, Bellanger AP, Bonhomme J, Bonnal C, Botterel F, Bougnoux ME, Brun S, Cassaing S, Cateau E, Chouaki T, Cornet M, Dannaoui E, Desbois-Nogard N, Durieux MF, Favennec L, Fekkar A, Gabriel F, Gangneux JP, Guitard J, Hasseine L, Huguenin A, Le Gal S, Letscher-Bru V, Mahinc C, Morio F, Nicolas M, Poirier P, Ranque S, Roosen G, Rouges C, Roux AL, Sasso M, Alanio A, Lortholary O, Lanternier F; French Mycoses Study Group. Paccoud O, et al. Clin Microbiol Infect. 2024 Jul;30(7):937-944. doi: 10.1016/j.cmi.2024.03.031. Epub 2024 Mar 29. Clin Microbiol Infect. 2024. PMID: 38556212
Cryptococcus neoformans Infections Differ Among Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Individuals: Results From a Nationwide Surveillance Program in France.
Paccoud O, Desnos-Ollivier M, Cassaing S, Boukris-Sitbon K, Alanio A, Bellanger AP, Bonnal C, Bonhomme J, Botterel F, Bougnoux ME, Brun S, Chouaki T, Cornet M, Dannaoui E, Demar M, Desbois-Nogard N, Durieux MF, Favennec L, Fekkar A, Gabriel F, Gangneux JP, Guitard J, Hasseine L, Huguenin A, Le Gal S, Letscher-Bru V, Mahinc C, Morio F, Nicolas M, Rouges C, Cateau E, Persat F, Poirier P, Ranque S, Roosen G, Roux AL, Sasso M, Lortholary O, Lanternier F; French Mycoses Study Group. Paccoud O, et al. Open Forum Infect Dis. 2023 Dec 22;11(2):ofad658. doi: 10.1093/ofid/ofad658. eCollection 2024 Feb. Open Forum Infect Dis. 2023. PMID: 38344129 Free PMC article.
Novel scores relevant to antimicrobial resistance and hospital-acquired infections developed with data from a multi-hospital consortium in the Parisian region of France.
Amarsy R, Granger B, Fournier S, Monteil C, Trystram D, Siorat V, Jarlier V, Robert J; Members of the Collégiale de Bactériologue – Virologie – Hygiène. Amarsy R, et al. J Hosp Infect. 2024 Jan;143:97-104. doi: 10.1016/j.jhin.2023.09.022. Epub 2023 Oct 28. J Hosp Infect. 2024. PMID: 37898407 Free article.
Candida spp. with acquired echinocandin resistance, France, 2004-2010.
Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O; French Mycoses Study Group. Dannaoui E, et al. Emerg Infect Dis. 2012 Jan;18(1):86-90. doi: 10.3201/eid1801.110556. Emerg Infect Dis. 2012. PMID: 22257484 Free PMC article.
Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study.
Bleibtreu A, Dortet L, Bonnin RA, Wyplosz B, Sacleux SC, Mihaila L, Dupont H, Junot H, Bunel V, Grall N, Razazi K, Duran C, Tattevin P, Dinh A, The Cefiderocol French Study Group OBO. Bleibtreu A, et al. Among authors: mihaila l. Microorganisms. 2021 Jan 30;9(2):282. doi: 10.3390/microorganisms9020282. Microorganisms. 2021. PMID: 33573148 Free PMC article.
35 results